Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 64.90
+0.39 (0.60%)
May 30, 2025, 11:30 AM CST
Hangzhou Alltest Biotech Revenue
Hangzhou Alltest Biotech had revenue of 208.48M CNY in the quarter ending March 31, 2025, with 4.28% growth. This brings the company's revenue in the last twelve months to 875.14M, up 21.80% year-over-year. In the year 2024, Hangzhou Alltest Biotech had annual revenue of 866.58M with 14.83% growth.
Revenue (ttm)
875.14M
Revenue Growth
+21.80%
P/S Ratio
5.74
Revenue / Employee
903.13K
Employees
969
Market Cap
5.02B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |